IP Verse

Csl competitive analysis

Latest oppositions filed by Csl

Explore patent oppositions filed by Csl against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP3116527
Method For Preparing Human Plasma ProteinsLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESMay 27, 2020
EP3071219
Methods Of Treating Antibody-Mediated Rejection In Organ Transplant Patients With C1-Esterase InhibitorSHIRE VIROPHARMAAug 14, 2019
EP2968434
C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor DeficencySHIRE VIROPHARMAMar 28, 2018
EP1974014
Oligopeptide-Free Cell Culture MediaBAXALTAJan 18, 2018
EP2214699
Method, Composition, And Article Of Manufacture For Providing Alpha-1 AntitrypsinGRIFOLS THERAPEUTICSAug 24, 2017
EP2329847
Use Of An Antibody Or An Immunotoxin That Selectively Binds To Cd123 To Impair Hematologic Cancer Progenitor CellsUNIVERSITY OF KENTUCKY RESEARCH FOUNDATIONAug 1, 2017
EP2314285
Lipophilic Drug Delivery Vehicle And Methods Of Us ThereofCHILDRENS HOSPITAL & RESEARCH CENTER AT OAKLANDMay 3, 2017
EP2356247
Method Of Producing Serum-Free Insulin-Free Factor ViiBAXALTAApr 14, 2016
EP2537862
A Process Of Purifying Coagulation Factor ViiiOCTAPHARMADec 7, 2015
EP2575762
Removal Of Serine Proteases By Treatment With Finely Divided Silicon DioxideBAXALTAApr 9, 2015

Latest patents of Csl opposed by its competitors

Explore Csl's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP4321220
Oct 29, 2025A1At For Reducing Risk Of Onset Of Acute Graft Versus Host Disease After Hematopoeitic Cell Transplantation1
EP3763384
Aug 28, 2024Pharmaceutical Product With Increased Stability Comprising Immunoglobulins1
EP3728287
Apr 10, 2024Protein Purification And Virus Inactivation With Alkyl Glycosides1
EP3794013
Feb 21, 2024Method And System Of Protein Extraction1
EP3715356
Oct 11, 2023Method Of Purifying Polypeptides1
EP3564267
Mar 17, 2021Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity2
EP3226895
Jul 22, 2020Pharmaceutical Product With Increased Stability Comprising Immunoglobulins1
EP3383894
May 6, 2020Improved Media For The Expression Of Recombinant Vitamin K-Dependent Proteins1
EP2513135
Apr 22, 2020Method Of Purifying Polypeptides2
EP2538975
Sep 18, 2019Immunoglobulin Preparation And Storage System For An Immunoglobulin Preparation1

Latest PTAB cases involving Csl

Discover the latest PTAB cases involving Csl, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 1, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Csl

IPR2019-00459Dec 21, 2018CSL BEHRINGSHIRE VIROPHARMA INCORPORATEDInstitution Denied
IPR2019-00459Dec 21, 2018CSL BEHRING GMBHSHIRE VIROPHARMA INCORPORATEDInstitution Denied
IPR2018-01345Jul 6, 2018CSL BEHRINGBIOVERATIV THERAPEUTICSInstitution Denied
IPR2018-01345Jul 6, 2018CSL BEHRINGBIOVERATIV THERAPEUTICS INC.Institution Denied
IPR2018-01345Jul 6, 2018CSL BEHRINGPIERCEInstitution Denied
IPR2018-01345Jul 6, 2018CSL BEHRING GMBHBIOVERATIV THERAPEUTICSInstitution Denied
IPR2018-01345Jul 6, 2018CSL BEHRING GMBHBIOVERATIV THERAPEUTICS INC.Institution Denied
IPR2018-01345Jul 6, 2018CSL BEHRING GMBHPIERCEInstitution Denied
IPR2018-01313Jul 2, 2018CSL BEHRINGBIOVERATIV THERAPEUTICSInstitution Denied
IPR2018-01313Jul 2, 2018CSL BEHRINGBIOVERATIV THERAPEUTICS INC.Institution Denied

Peer Comparison New

IP litigation analysis comparing Csl with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CSL24 - -
CHILDRENS HOSPITAL & RESEARCH CENTER AT OAKLAND - 1 - -
DE CLERCQ & PARTNERS5 - - -
HOFFMANN EITLE191 - - -